Prediction of progression of non-muscle invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: A prospective study

被引:0
|
作者
Zwarthoff, Ellen
Burger, Maximilian
Van der Aa, Madelon
Van Oers, Johanna
Brinkmann, Anke
Van der Kwast, Theodorus
Steyerberg, Ewout
Stoehr, Robert
Kirkels, Wim
Denzinger, Stefan
Wild, Peter
Wieland, Wolf
Hofstaedter, Ferdinand
Hartmann, Arndt
机构
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Regensburg, Regensburg, Germany
[3] Toronto Gen Hosp, Toronto, ON, Canada
[4] Univ Hosp Zurich, Zurich, Switzerland
[5] Univ Erlangen Nurnberg, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4951
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
    Soukup, Viktor
    Capoun, Otakar
    Cohen, Daniel
    Hernandez, Virginia
    Babjuk, Marek
    Burger, Max
    Comperat, Eva
    Gontero, Paolo
    Lam, Thomas
    MacLennan, Steven
    Mostafid, A. Hugh
    Palou, Joan
    van Rhijn, Bas W. G.
    Roupret, Morgan
    Shariat, Shahrokh F.
    Sylvester, Richard
    Yuan, Yuhong
    Zigeuner, Richard
    EUROPEAN UROLOGY, 2017, 72 (05) : 801 - 813
  • [32] Assessment of recurrence and progression risk in patients with non-muscle invasive bladder cancer
    Rolevich, A. I.
    Mirilenko, L. V.
    ONKOUROLOGIYA, 2016, 12 (04): : 119 - 130
  • [33] Methylation and clinicopathological markers for predicting progression of non-muscle invasive bladder cancer
    Smal, M. P.
    Rolevich, A. I.
    Nabebina, T. I.
    Krasny, S. A.
    Goncharova, R. I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 523 - 524
  • [34] Tumor mutation burden to predict progression in high-risk non-muscle invasive bladder cancer.
    Meeks, Joshua
    Carneiro, Benedito A.
    Pai, Sachin Gopalkrishn
    Oberlin, Daniel
    Rademaker, Alfred
    Fedorchak, Kyle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [35] The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study
    van Kessel, Kim E.
    Zwarthoff, Ellen C.
    UROLOGY, 2015, 86 (06) : 1190 - 1191
  • [36] FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
    Tomlinson, D. C.
    Baldo, O.
    Hamden, P.
    Knowles, M. A.
    JOURNAL OF PATHOLOGY, 2007, 213 (01): : 91 - 98
  • [37] Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
    C Blick
    A Ramachandran
    S Wigfield
    R McCormick
    A Jubb
    F M Buffa
    H Turley
    M A Knowles
    D Cranston
    J Catto
    A L Harris
    British Journal of Cancer, 2013, 109 : 50 - 59
  • [38] Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
    Blick, C.
    Ramachandran, A.
    Wigfield, S.
    McCormick, R.
    Jubb, A.
    Buffa, F. M.
    Turley, H.
    Knowles, M. A.
    Cranston, D.
    Catto, J.
    Harris, A. L.
    BRITISH JOURNAL OF CANCER, 2013, 109 (01) : 50 - 59
  • [39] A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
    Hai Huang
    Ao Liu
    Yiming Liang
    Yaqun Xin
    Jiacheng Liu
    Yining Hao
    Da Huang
    Lu Chen
    Wei Li
    Guangliang Jiang
    Yuhua Huang
    Yaoting Xu
    Jie Zhang
    Tonghui Ma
    Danfeng Xu
    Yi Gao
    BMC Medicine, 21
  • [40] Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
    Vedder, Moniek M.
    Marquez, Mirari
    de Bekker-Grob, Esther W.
    Calle, Malu L.
    Dyrskjot, Lars
    Kogevinas, Manoils
    Segersten, Ulrika
    Malmstrom, Per-Uno
    Algaba, Ferran
    Beukers, Willemien
    Orntoft, Torben F.
    Zwarthoff, Ellen
    Real, Francisco X.
    Malats, Nuria
    Steyerberg, Ewout W.
    PLOS ONE, 2014, 9 (06):